Synthesis 2023; 55(20): 3364-3372
DOI: 10.1055/a-2147-2620
paper

Rhodium-Catalyzed C–H Activation of 2-Arylquinazolinones and Cyclization with Elemental Sulfur via C–S/S–N Bond Formation to Access 7H-Benzo[4,5]isothiazolo[3,2-b]quinazolinones

Xinqin Zhang
,
Qiong Wu
,
Qin Yang
,
Yang Fu
,
Yiyuan Peng
Financial support from National Natural Science Foundation of China (no. 21762020 and 22261027) is gratefully acknowledged.


Abstract

An efficient method for the synthesis of 7H-benzo[4,5]isothiazolo[3,2-b]quinazolin-7-ones by the reaction of 2-arylquinazolin-4(3H)-ones and elemental sulfur is described. The rhodium-catalyzed C–H activation of 2-arylquinazolinones and cyclization with elemental sulfur via one-step formation of C–S/N–S bonds to give the corresponding 7H-benzo[4,5]isothiazolo[3,2-b]quinazolinones is realized in good to high yields with good functional group tolerance.

Supporting Information



Publication History

Received: 29 May 2023

Accepted after revision: 02 August 2023

Accepted Manuscript online:
02 August 2023

Article published online:
07 September 2023

© 2023. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

    • 1a Scott KA, Njardarson JT. Top. Curr. Chem. 2018; 376: 5
    • 1b Ilardi EA, Vitaku E, Njardarson JT. J. Med. Chem. 2014; 57: 2832
    • 1c Smith BR, Eastman M, Njardarson JT. J. Med. Chem. 2014; 57: 9764

      For recent reviews, see:
    • 2a Zhang JP, Zhang YB, Lin JB, Chen XM. Chem. Rev. 2012; 112: 1001
    • 2b Craine L, Raban M. Chem. Rev. 1989; 89: 689
    • 2c Fontana G. Curr. Bioact. Compd. 2010; 6: 284
    • 2d Bradshaw TD, Wrigley S, Shi DF, Schultz RJ, Paull KD, Stevens MF. G. Br. J. Cancer 1998; 77: 745
    • 2e Mortimer CG, Wells G, Crochard JP, Stone EL, Bradshaw TD, Stevens MF. G, Westwell AD. J. Med. Chem. 2006; 49: 179
    • 2f Tekiner-Gulbas B, Temiz-Arpaci O, Yildiz I, Altanlar N. Eur. J. Med. Chem. 2007; 42: 1293
    • 2g Keri RS, Patil MR, Patil SA, Bugagumpi S. Eur. J. Med. Chem. 2015; 89: 207

      For excellent reports, see:
    • 3a Novick RM, Nelson ML, Unice KM, Keenan JJ, Paustenbach DJ. Food Chem. Toxicol. 2013; 56: 60
    • 3b Dahlin J, Isaksson M. Contact Dermatitis 2015; 73: 60
    • 4a Younce JR, Davis AA, Black KJ. J. Parkinsons Dis. 2018; 9: 63
    • 4b Shirley M. Drugs Ther. Perspect. 2021; 37: 347
    • 4c Riva MA, Albert U, De Filippis S, Vita A, Berardis DDe. Ther. Adv. Psychopharmacol. 2021; 11: 1
    • 4d Gan Z, Zhang M, Han H, Zhu Q, Li K. Bipolar Disord. 2020; 22: 425
    • 4e Haranishi Y, Hara K, Terada T. Pharmacol. Biochem. Behav. 2020; 195: 172964
    • 5a Silva AD. O, McQuade J, Szostak M. Adv. Synth. Catal. 2019; 361: 2050
    • 5b Li T, Yang L, Ni KD, Shi ZY, Li F, Chen DY. Org. Biomol. Chem. 2016; 14: 6297
    • 6a Bhakuni BS, Balkrishna SJ, Kumar A, Kumar S. Tetrahedron Lett. 2012; 53: 1354
    • 6b Krasikova V, Katkevics M. Chem. Heterocycl. Comp. 2013; 48: 1684
    • 6c Xie H, Li G, Zhang F, Xiao F, Deng GJ. Green Chem. 2018; 20: 827
    • 7a Chen FJ, Liao G, Li X, Wu J, Shi BF. Org. Lett. 2014; 16: 5644
    • 7b Guo JR, Gong JF, Song MP. Org. Biomol. Chem. 2019; 17: 5029
  • 8 Moon S, Nishii Y, Miura M. Org. Lett. 2021; 23: 49
  • 9 Tausch E, Ljungström V, Agathangelidis A, Zapatka M, Scarfò L, Jebaraj BM. C, Yosifov DY, Müller A, Munugalavadla V, Degenhardt JD, Ghia P, Rosenquist R, Stilgenbauer S. Blood 2022; 139: 3340

    • For reviews, see:
    • 10a He D, Wang ML, Zhao SY, Shu YS, Zeng HL, Xiao C, Lu C, Liu YY. Fitoterapia 2017; 119: 136
    • 10b Kshirsagar UA. Org. Biomol. Chem. 2015; 36: 9336
    • 10c Micheal JP. Nat. Prod. Rep. 2008; 25: 166
    • 10d Michael JP. Nat. Prod. Rep. 2007; 24: 223
    • 10e Mhaske SB, Argade NP. Tetrahedron 2006; 62: 9787
    • 10f Michael JP. Nat. Prod. Rep. 2000; 17: 603

      For recent reviews on the biological activities of quinazolinone, see:
    • 11a Gatadi S, Lakshmi TV, Nanduri S. Eur. J. Med. Chem. 2019; 170: 157
    • 11b Hameed A, Al-Rashida M, Uroos M, Ali SA, Arshia, Ishtiaq M, Khan KM. Expert Opin. Ther. Pat. 2018; 28: 281

    • For selective recent reports, see:
    • 11c Ghorab MM, Alqahtani AS, Soliman AM, Askar AA. Int. J. Nanomed. 2020; 15: 3161
    • 11d Soliman AM, Karam HM, Mekkawy MH, Ghorab MM. Eur. J. Med. Chem. 2020; 197: 112333

      For recent reviews, see:
    • 12a Plescia F, Maggio B, Daidone G, Raffa D. Eur. J. Med. Chem. 2021; 213: 113070
    • 12b Auti PS, George G, Paul AT. RSC Adv. 2020; 10: 41353
    • 12c Xing ZM, Wu WH, Miao YX, Tang YQ, Zhou YK, Zheng LF, Song ZB, Peng YY. Org. Chem. Front. 2021; 8: 1867
    • 12d Mohammadkhani L, Heravi MM. Front. Chem. 2020; 8: 580086
    • 12e Ghosh P, Gangulya B, Das S. Org. Biomol. Chem. 2020; 18: 4497
    • 12f Reddy MM, Sivaramakrishna A. J. Heterocycl. Chem. 2019; 57: 942

      For selected recent reports, see:
    • 13a Liu HL, Li XT, Tian HZ, Sun XW. Org. Lett. 2021; 23: 4579
    • 13b Alafeefy AM, Ashour AE, Prasad O, Sinha L, Pathak S, Alasmari FA, Rishi AK, Abdel-Aziz HA. Eur. J. Med. Chem. 2015; 92: 191
  • 14 Wu Q, Deng ZH, Xie DY, Liu Y, Yang Q, Fu Y, Peng YY. Tetrahedron 2022; 124: 132911
    • 15a Kang SD, Li JX, Yang Q, Song ZB, Peng YY. Eur. J. Org. Chem. 2022; e202200472
    • 15b Huang J, Chen W, Liang JZ, Yang Q, Deng ZH, Song ZB, Peng YY. Org. Chem. Front. 2021; 8: 6837
    • 15c Wang N, Yang Q, Deng ZH, Mao XC, Peng YY. ACS Omega 2020; 14635
    • 15d Lou MH, Deng ZH, Mao XC, Fu Y, Yang Q, Peng YY. Org. Biomol. Chem. 2018; 16: 1851
    • 15e Zhang YG, Huang J, Deng ZH, Mao XC, Peng YY. Tetrahedron 2018; 74: 2330
    • 15f Jiang X, Yang Q, Yuan JJ, Deng ZH, Mao XC, Peng YY, Yu CY. Tetrahedron 2016; 72: 1238